SEI Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
SEI Investments's PTGX Position: Q3 2026 in Review
SEI Investments increased its Protagonist Therapeutics (PTGX) stake by 12% in Q3 2026, buying an estimated $1.6M and bringing the position to 103,954 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #926.
SEI Investments first reported a position in PTGX in Q1 2021 and has held it in 23 quarters since. 380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- SEI Investments held 103,954 shares of Protagonist Therapeutics worth $14.6M as of Q3 2026.
- SEI Investments bought 11,205 Protagonist Therapeutics shares in Q3 2026, an estimated $1.6M.
- Protagonist Therapeutics made up 0.01% of SEI Investments's portfolio in Q3 2026, its #926 holding.
- SEI Investments first reported a position in Protagonist Therapeutics in Q1 2021 and has held it in 23 quarters since.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.